{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P04141",
      "entity_text" : "CSF",
      "entity_type" : "protein"
    },
    "is_direct" : true,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:7079450",
      "entity_text" : "PD",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Importantly, an outstanding question in the field is whether PD patients with LRRK2 mutations (such as G2019S) have altered expression of total or phosphorylated LRRK2 in brain and CSF.",
  "reading_complete" : "2020-08-05T19:58:52Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:57:38Z",
  "evidence" : [ "PD patients with LRRK2 mutations (such as G2019S) have altered expression of total or phosphorylated LRRK2 in brain and CSF" ],
  "pmc_id" : "7262382",
  "score" : 0
}